MedOncMD
Welcome to MedOncMD, your trusted source for cutting-edge information in the battle against cancer. Dr. Sajeve S. Thomas is a certified medical oncologist and is affiliated with the Orlando Health UF Health Cancer Center, specializing in melanoma, sarcoma, and gastrointestinal malignancies. On MedOncMD we share insights that your oncologist might not have the time to provide.
With over 12 years of experience in medical oncology, Dr. Thomas has been a beacon of expertise at the Orlando Health UF Health Cancer Center. In his extensive career, he has been a key figure in major teaching hospitals, regularly lecturing to medical professionals, and collaborating with top pharmaceutical companies on groundbreaking immunotherapy clinical trials. Dr. Thomas served as a consultant for Foundation One molecular tumor boards globally, contributing his expertise to countries like Spain, China, Australia, and India. His journey in medicine began at the University of Florida College of Medicine, where he earned his medical degree. During his internal medicine residency at the University of South Florida College of Medicine, he received the Outstanding Resident award.
Additionally, he acts as an expert witness in medical malpractice cases, shedding light on potential misdiagnoses and delayed diagnoses regardless if plaintiff or defense. He aims to bridge the gap between patients and medical knowledge, making complex information easily understandable.
Explore MedOncMD to access the latest data presented at oncology conferences and published in major peer-reviewed journals. Dr. Thomas shares personal experiences, delivering a unique perspective on a day in the life of a practicing medical oncologist. Sign up with your email to receive periodic blog posts and stay informed. For any questions or comments, reach out through the contact form.
I hope you enjoy this website. If you have any questions or comments, please contact me through the contact form.
Disclaimer: The information provided on this site is intended as general medical education only and not to be taken as medical advice. Your specific situation may vary and you should speak with your treating physicians. The views/interpretations on this site are intended to be my opinion/interpretation alone of the guidelines, published articles and presented abstracts. The information on this site does not represent my employer in a way, shape, or form. My posts and contents are my own. MedOncMD.com is owned by Thomas and Chander Medical Consulting LLC.
- Reevaluating Radiation in Resectable Gastric Cancer: Insights from the TOPGEAR Trial
- When Hepatic Tumors Are Rumors: A Case of Peliosis Hepatis Mimicking Malignancy
- Innovative Advances in Bladder Cancer Treatment: Durvalumab Plus Chemotherapy in the NIAGARA Trial
- New Horizons in Colon Cancer Treatment: Neoadjuvant Immunotherapy for Mismatch Repair–Deficient High Risk Stage II/III Colon Cancer
- A Breakthrough in Treating IgG4-Related Disease: The Promise of Inebilizumab
